Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by CCAbbott888on Apr 20, 2019 1:50pm
97 Views
Post# 29651126

RE:RE:RE:RE:RE:RE:One more time lol

RE:RE:RE:RE:RE:RE:One more time lol
beenaround2019 wrote: To CC Abbott

How will the rights offering be conducted?

Does it come in the mail?
How do I reply and send money?

thanks,


beenaround2019 I've never been through a rights offer before, so I don't know for certain.

My guess is that it would be a similar process as the dividend or proxy materials: those who are eligible (own PLI shares on the Record date) will be notified by their brokage electronically or by mail and they will then have 30 days to subscribe.  Upon closing, the company will total the number of the subscribed shares and see if it's over the cap, if so, the shares will be prorated among the subscribers (not sure how this works).  Then the subscribers will be notified by the company (via their brokage) again on the number of shares they can purchase in the rights offer, then they can complete the purchse via brokage.  

Bullboard Posts